Research and Markets: GSK's Fendrix (Prophylactic Hepatitis B Virus Vaccines) Market 2014- Forecast Opportunities to 2022
Update on GSK ’S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer
ADR Shares End Mixed; RBS Shares Active
UPDATE: FTSE rises for second day as miners push higher
FTSE rises for second day as miners push higher
Our top managers continue to focus on higher-quality businesses rather than seeking out bargains in a market that (in many of their minds) has become fully valued.
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
NetScientific Partners with Peter Thiel’s Breakout Labs to Increase Support for Companies at the Forefront of Scientific Innovation
GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...
More than a dozen analyst-approved foreign large-cap funds own these names.